Why Is HealthQuad Launching A New Healthcare-Focused Investment Fund?
Healthcare-focused venture capital firm HealthQuad has announced the first close of its third investment vehicle, HealthQuad Fund III, securing commitments worth ₹550 crore and crossing one-third of its target corpus of ₹1,700 crore.
The fund marks HealthQuad’s largest investment vehicle to date and signals continued investor confidence in India’s rapidly evolving healthcare and healthtech ecosystem.
Backed by healthcare focused investment platform Quadria Group, the new fund will focus on early growth stage startups building technology driven solutions across healthcare delivery, medtech, healthtech, and biopharma technology.
The announcement comes as India’s healthcare industry undergoes significant transformation driven by digital adoption, artificial intelligence, diagnostics innovation, and growing demand for accessible healthcare services.
Who Has Backed Fund III?
HealthQuad said the first close attracted commitments from both existing and new limited partners (LPs).
The investor base includes local and international fund-of-funds, institutional investors, and family offices.
The strong participation from returning investors reflects confidence in HealthQuad’s track record of identifying and scaling healthcare focused startups.
The firm has also already deployed capital from the new fund, making its first investment in Lifesigns, an AI-powered remote patient monitoring platform focused on improving patient outcomes through real-time healthcare monitoring.
HealthQuad added that it is actively evaluating multiple investment opportunities across the healthcare value chain.
What Will Fund III Invest In?
HealthQuad Fund III will focus on companies operating at the intersection of healthcare and technology.
The fund’s investment mandate includes:
- Healthtech platforms
- Medical technology startups
- Biopharma technology companies
- Healthcare delivery businesses
- AI-driven healthcare solutions
- Digital diagnostics and monitoring platforms
The firm believes these segments will play a central role in shaping the future of healthcare in India.
According to HealthQuad, technology-enabled healthcare businesses could account for more than 40% of India’s projected $600 billion healthcare market by 2030.
How Is HealthQuad Positioned In India’s Startup Ecosystem?
Founded in 2016, HealthQuad has emerged as one of India’s most active healthcare-focused venture capital investors.
Over the past decade, the firm has built a portfolio spanning multiple healthcare categories, backing companies focused on diagnostics, artificial intelligence, healthcare infrastructure, wellness, and enterprise healthcare solutions.
Its previous funds have invested in more than 18 startups, including well-known names such as GoApptiv, Qure.ai, Redcliffe Labs, CureSkin, Strand Life Sciences, Medikabazaar, THB, Wysa, and ekincare.
Several of these companies have gone on to become category leaders within India’s healthcare technology ecosystem.
Why Is Healthcare Becoming A Major Venture Capital Theme?
Healthcare has emerged as one of the most attractive investment sectors for venture capital firms globally.
In India, rising healthcare expenditure, increasing digital adoption, growing insurance penetration, and greater awareness around preventive care are creating significant opportunities for innovation.
At the same time, artificial intelligence, data analytics, telemedicine, remote patient monitoring, and personalized healthcare solutions are reshaping traditional healthcare delivery models.
Investors increasingly view healthcare as a long-term structural growth opportunity rather than a cyclical investment theme.
What Changed After HealthQuad’s Separation From KOIS?
The launch of Fund III follows a significant restructuring within the broader investment platform.
After separating from KOIS in 2025, Quadria Group retained the majority of the team that had managed HealthQuad Funds I and II.
The organization also strengthened its leadership team with the addition of Rahul Agarwal and Namit Chugh.
Fund III will continue to be managed by HealthQuad Advisors, a wholly-owned subsidiary of Quadria Group, through its leadership team comprising Amit Varma, Abrar Mir, and Sunil Thakur.
The continuity of leadership is expected to ensure consistency in investment philosophy and portfolio management.
Why Did HealthQuad Invest In Lifesigns?
The fund’s first investment offers insight into its future strategy.
Lifesigns operates in the rapidly growing remote patient monitoring segment, leveraging artificial intelligence to monitor patients continuously and improve clinical decision-making.
As healthcare systems globally move toward preventive and continuous care models, remote monitoring technologies are becoming increasingly important.
The investment highlights HealthQuad’s interest in AI-driven healthcare solutions that can improve access, efficiency, and patient outcomes at scale.
What Lies Ahead For HealthQuad Fund III?
With ₹550 crore already committed and fundraising continuing toward its ₹1,700 crore target, HealthQuad is positioning itself to become one of the largest dedicated healthcare-focused venture investors in India.
The firm believes healthcare startups that improve affordability, accessibility, and quality of care will drive the next wave of innovation in the sector.
As India’s healthcare market expands toward an estimated $600 billion opportunity by the end of the decade, HealthQuad aims to back the founders building the infrastructure, technology, and services that will shape the future of healthcare delivery.
